Ubs Group Ag Bridge Bio Pharma, Inc. Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $5.88 Million - $7.69 Million	245,800 Added 6.36%	4,109,300 $105 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $106 Million - $156 Million	3,863,500 New	3,863,500 $119 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $160,809 - $217,921	12,100 New	12,100 $208,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $55,762 - $261,708	4,900 New	4,900 $82,000

294

170M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.06B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.